|
Medtronic Plc (NYSE: MDT) |
|
|
|
Medtronic Plc's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 2.51% in the third quarter 2025, year on year to cumulative value of $33,199 million, Medtronic Plc's revenue per employee grew on a trailing twelve months basis to $ 331,990. The productivity of Medtronic Plc's employees was 0.0%, above the company average. Within the Healthcare sector Employees of 123 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1182, from total ranking in previous quarter at 1730. Medtronic Plc has 100,000 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
MDT Revenue per Employee |
(Jan 24 2025) III. Quarter |
(Oct 25 2024) II. Quarter |
(Jul 26 2024) I. Quarter |
(Apr 26 2024) IV. Quarter |
(Jan 26 2024) III. Quarter |
Y / Y Revenue Change |
2.51 % |
5.25 % |
2.77 % |
0.53 % |
4.68 % |
Sales per Employee (TTM) $ |
331,990 |
329,960 |
325,770 |
323,640 |
323,190 |
MDT's Total
Ranking |
# 1182 |
# 1730 |
# 1551 |
# 1524 |
# 972 |
Seq. Revenue Change |
-1.32 % |
6.17 % |
-7.85 % |
6.18 % |
1.32 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 436,930 |
$ 237,042 |
$ 115,093 |
(Jan 27 2017) |
|
(July 26. 2006) |
Date modified: 2025-02-26T13:29:17+00:00
Companies with similar Revenue per Employee for 12 months ending Jan 24 2025, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Jan 24 2025 | Number of Employees Jan 24 2025 | Ensysce Biosciences Inc | 578,892.33 | $ 5.210 Million | 9 | Bicycle Therapeutics Plc | 578,278.69 | $ 35.275 Million | 61 | Moderna Inc | 577,857.14 | $ 3,236.000 Million | 5,600 | Sol gel Technologies Ltd | 576,900.00 | $ 11.538 Million | 20 | Fortress Biotech Inc | 571,039.60 | $ 57.675 Million | 101 | Phibro Animal Health Corporation | 569,646.91 | $ 1,105.115 Million | 1,940 | Ginkgo Bioworks Holdings Inc | 567,607.50 | $ 227.043 Million | 400 | Monte Rosa Therapeutics Inc | 564,343.28 | $ 75.622 Million | 134 | Pacira Biosciences inc | 563,930.81 | $ 700.966 Million | 1,243 | Vaxart Inc | 562,745.10 | $ 28.700 Million | 51 | Organogenesis Holdings Inc | 559,214.62 | $ 482.043 Million | 862 | Nature s Sunshine Products inc | 553,953.60 | $ 453.688 Million | 819 | Neogen Corporation | 550,770.61 | $ 921.990 Million | 1,674 | Schrodinger Inc | 549,044.97 | $ 207.539 Million | 378 | Zynex inc | 542,068.57 | $ 189.724 Million | 350 | Tango Therapeutics Inc | 539,346.15 | $ 42.069 Million | 78 | Flora Growth Corp | 537,815.79 | $ 40.874 Million | 76 | Edap Tms Sa | 535,878.21 | $ 71.808 Million | 134 | Immucell Corp | 529,863.38 | $ 26.493 Million | 50 | Harrow Inc | 521,908.38 | $ 199.369 Million | 382 | Caredx Inc | 519,105.75 | $ 333.785 Million | 643 | Natera Inc | 515,308.53 | $ 1,696.911 Million | 3,293 | Tela Bio Inc | 514,947.37 | $ 68.488 Million | 133 | Prophase Labs Inc | 510,750.00 | $ 12.258 Million | 24 | Enanta Pharmaceuticals Inc | 508,328.24 | $ 66.591 Million | 131 | Veracyte Inc | 505,699.39 | $ 412.145 Million | 815 | Xtant Medical Holdings Inc | 505,241.38 | $ 117.216 Million | 232 | Globus Medical Inc | 503,871.00 | $ 2,519.355 Million | 5,000 | Avantor Inc | 502,488.89 | $ 6,783.600 Million | 13,500 | Puma Biotechnology Inc | 501,017.39 | $ 230.468 Million | 460 |
|